AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12739832
Drug: GM-CSF (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF (not specified dose)
Trial: 11789263
Drug: Conventional medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medicine (CM)
Trial: 9383258
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg/day
Trial: 8222794
Drug: Clarithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (500 mg twice daily for 7 to 14 days)
Trial: 8222794
Drug: Cefixime (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (400 mg once daily for 7 to 14 days)
Trial: 26726885
Drug: Ibuprofen (400mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400mg every 8 hrs)
Trial: 18983789
Drug: Bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine with midazolam (30 ml of 0.5% bupivacaine with midazolam 50 microg x kg‐1)
Trial: 18983789
Drug: Bupivacaine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (30 ml of 0.5% bupivacaine)
Trial: 11074901
Drug: Multicomponent intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multicomponent intervention (patient education, training for participation, self-monitoring of prothrombin time, guideline-based management of warfarin dosing)
Trial: 8315546
Drug: Meperidine 2
RxNorm normalized name: meperidine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 2 mg/kg (M)
Trial: 8315546
Drug: Low-dose meperidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose meperidine 1 mg/kg and diazepam 0.1 mg/kg (M low+D)
Trial: 8315546
Drug: High-dose meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose meperidine 2 mg/kg and diazepam 0.1 mg/kg (M high+D)
Trial: 8315546
Drug: Diazepam 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.1 mg/kg (D)
Trial: 27247843
Drug: Medication (active-comparator)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (active-comparator)
Trial: 27247843
Drug: Medication (medication)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (medication)
Trial: 12566494
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 2 mg Cu/d for 6 weeks
Trial: 12566494
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 1.0 mg Cu/d during equilibration
Trial: 10385496
Drug: Single-dose ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose ascorbic acid (2 g PO)
Trial: 10385496
Drug: Long-term ascorbic
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term ascorbic acid (500 mg/d)
Trial: 31119466
Drug: IP6 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IP6 (600 mg twice daily)
Trial: 23348636
Drug: Mericitabine 500
RxNorm normalized name: Emtricitabine
DrugBank: Emtricitabine (DB00879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Mericitabine 500 mg BID for 12 weeks + Peg-IFNα-2a/RBV
Trial: 23348636
Drug: Mericitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mericitabine 1000 mg BID for 8 weeks + Peg-IFNα-2a/RBV
Trial: 23348636
Drug: Mericitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mericitabine 1000 mg BID for 12 weeks + Peg-IFNα-2a/RBV
Trial: 19297102
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17‐beta estradiol daily and 0.35 mg norethindrone 3 days/week
Trial: 17989859
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (50 g daily for 3 months)
Trial: 15381516
Drug: Manipulative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manipulative therapy (up to 6 treatment sessions in a 12-week period)
Trial: 11378603
Drug: Pentoxifylline (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (loading bolus of 300 mg followed by a continuous infusion of 1.5 mg.kg‐1.hr‐1 until the second postoperative day)
Trial: 8078656
Drug: Other three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other three lidocaine solutions (not specified)
Trial: 2676654
Drug: 1500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg/day clofibrate
Trial: 25973909
Drug: ABT-089 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-089 (5, 10, 15, 20, 30, or 35 mg once daily)
Trial: 10960046
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of GTN (0.5 microg/kg per minute for 20 min)
Trial: 10960046
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of GTN
Trial: 3876031
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g every four hours)
Trial: 3876031
Drug: Cimetidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (2 g intravenously)
Trial: 3876031
Drug: Antacids (every
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids (every two hours)
Trial: 3876031
Drug: Pirenzepine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (50 mg intravenously daily)
Trial: 29091470
Drug: Caffeinated chewing
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated chewing gum (200 mg caffeine)
Trial: 29091470
Drug: Caffeinated chewing
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated chewing gum (200 mg caffeine) in low habitual caffeine consumers (<40 mg/day)
Trial: 29091470
Drug: Placebo (noncaffeinated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (noncaffeinated chewing gum) in low habitual caffeine consumers (<40 mg/day)
Trial: 29091470
Drug: Caffeinated chewing
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated chewing gum (200 mg caffeine) in moderate/high habitual caffeine consumers (>130 mg/day)
Trial: 29091470
Drug: Placebo (noncaffeinated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (noncaffeinated chewing gum) in moderate/high habitual caffeine consumers (>130 mg/day)
Trial: 27046296
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (mirror therapy and comparison)
Trial: 19096961
Drug: 30-60 min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-60 min of oral and written information on lifestyle intervention
Trial: 10758049
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MRCA and x-ray coronary angiography
Trial: 23519576
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate 600 mg
Trial: 16430561
Drug: Levobupivacaine 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 12 mg
Trial: 16430561
Drug: Ropivacaine 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 17 mg
Trial: 11773294
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus TAM
Trial: 9564793
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAA) 400 microg twice daily
Trial: 7752836
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of Coenzyme Q10 (CoQ10) once a week for 6 weeks
Trial: 3357071
Drug: VT‐1 (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VT‐1 (no uncertainty, prescribed therapy)
Trial: 3357071
Drug: VT‐2 (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VT‐2 (no uncertainty, prescribed therapy)
Trial: 3357071
Drug: VT‐3 (expressed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VT‐3 (expressed uncertainty, prescribed antibiotics without resolution)
Trial: 31332977
Drug: Daily vacuuming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vacuuming of mattresses for 2 weeks
Trial: 23743404
Drug: Local BH4
RxNorm normalized name: 6R-BH4
DrugBank: Sapropterin (DB00360)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Local BH4 administration
Trial: 16364159
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 200 microg twice daily (400 microg/day)
Trial: 15243285
Drug: Transdermal 17beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta‐estradiol (50 microg/day) and nomegestrol (5 mg/day for 12 days/month)
Trial: 15243285
Drug: Transdermal 17beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta‐estradiol and nomegestrol (HT)
Trial: 10654500
Drug: Propranolol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (20 mg four times daily)
Trial: 10654500
Drug: Propranolol +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol + Magnesium (18 g over 24 hours)
Trial: 8356371
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoprofen controlled release (morning dose)
Trial: 8356371
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoprofen controlled release (evening dose)
Trial: 8356371
Drug: Both morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both morning and evening doses of ketoprofen
Trial: 28833181
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment procedures (radiofrequency ablation, microdebrider-assisted inferior turbinoplasty)
Trial: 22543555
Drug: Neurocognitive and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurocognitive and perceptive rehabilitation treatment (TG)
Trial: 22543555
Drug: Common physical
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common physical therapy (CG)
Trial: 20861328
Drug: Mtb72F/AS02(A) (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mtb72F/AS02(A) (10 μg antigen)
Trial: 20861328
Drug: Mtb72F/AS02(A) (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mtb72F/AS02(A) (40 μg antigen)
Trial: 20861328
Drug: Mtb72F/AS02(A) (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mtb72F/AS02(A) (10 or 40 μg antigen)
Trial: 18384663
Drug: 20‐mg rabeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mg rabeprazole once daily for 4 weeks
Trial: 18384663
Drug: 20‐mg rabeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mg rabeprazole once daily for 8 weeks
Trial: 8363291
Drug: 12.5mg of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5mg of timolol (2.5mL of timolol 0.5% ophthalmic solution)
Trial: 8363291
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of caffeine and timolol
Trial: 30982378
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg twice daily plus MTX
Trial: 30982378
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg every 2 weeks plus MTX
Trial: 28280092
Drug: Enzalutamide monotherapy
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide monotherapy (n = 29)
Trial: 28280092
Drug: Enzalutamide in
RxNorm normalized name: Product containing enzalutamide in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzalutamide in combination with endocrine therapies (n = 70)
Trial: 28280092
Drug: Exemestane 50
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane 50 mg/day given with enzalutamide
Trial: 11346805
Drug: Transesophageal echocardiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transesophageal echocardiography guided treatment
Trial: 9288409
Drug: Secobarbital sodium
RxNorm normalized name: Secobarbital Sodium
DrugBank: Secobarbital (DB00418)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Secobarbital sodium (2.9 mg/kg body weight)
Trial: 8506770
Drug: Antimicrobial prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial prophylaxis (ceftriazone, 1 gr intramuscular)
Trial: 21765198
Drug: Stepwise protocol
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepwise protocol for the treatment of pain (paracetamol, morphine, buprenorphine transdermal patch, pregabaline) for eight weeks
Trial: 21765198
Drug: Stepwise protocol
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepwise protocol for the treatment of pain
Trial: 12750665
Drug: 2-phase treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-phase treatment with headgear/biteplate
Trial: 8795760
Drug: Topical verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical verapamil 0.063%, 0.125%, and 0.25%
Trial: 8795760
Drug: Topical verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical verapamil 0.25%
Trial: 6152055
Drug: IV alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV alprazolam (1.0 mg)
Trial: 6152055
Drug: Oral alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alprazolam (1.0 mg)
Trial: 6152055
Drug: IV and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV and oral alprazolam (1.0 mg)
Trial: 31553712
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline injection (experimental neck pain)
Trial: 26724641
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg/d) plus gefitinib (250 mg/d)
Trial: 26724641
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg/d) plus placebo
Trial: 18612534
Drug: Anticoagulant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant therapy (specific dosage and duration not mentioned)
Trial: 18612534
Drug: Risk score
RxNorm normalized name: fecal microbiota spores, live Oral Capsule [Vowst]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk score based on six variables (age >75 years, recent bleeding, cancer, creatinine levels >1.2 mg/dl, anemia, pulmonary embolism)
Trial: 10392324
Drug: Inhaled triamcinolone
RxNorm normalized name: triamcinolone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled triamcinolone acetonide (800 mcg)
Trial: 10392324
Drug: Intravenous triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous triamcinolone acetonide (400 mcg)
Trial: 10392324
Drug: Inhaled triamcinolone
RxNorm normalized name: triamcinolone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled triamcinolone acetonide (800 mcg) with oral charcoal
Trial: 8721464
Drug: Patient-controlled premedication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled premedication by i.v. midazolam (mean dose 0.7 mg, 0.7-1.1 mg for anxious patients, 1.7 mg for those using the device)
Trial: 8721464
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 4 mg i.v. midazolam (1-hour infusion)
Trial: 30058609
Drug: Procedures for
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Procedures for estimating biological occupational exposure limits (BOELs) using regression analysis on 14 organic solvents.
Trial: 19393473
Drug: Pamidronate, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate, 1 mg/kg, perioperatively and then at 1, 4, 8, and 12 months
Trial: 8397999
Drug: One pill
RxNorm normalized name: Geone Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One pill each day for < or = 63 weeks
Trial: 3522347
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride treatment
Trial: 29984564
Drug: Aquatic physical
RxNorm normalized name: Mentha aquatica leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquatic physical training (APT) performed twice a week for 16 weeks
Trial: 17052967
Drug: G-CSF during
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF during radiotherapy (group B)
Trial: 3081399
Drug: Nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiinflammatory drugs
Trial: 24646858
Drug: Mean baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean baseline 24‐h urinary sodium excretion of 3.46 g/day
Trial: 24646858
Drug: Urine sodium
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urine sodium under 3 g/day
Trial: 24646858
Drug: Urine sodium
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urine sodium ⩾ 3 g/day
Trial: 18988091
Drug: SPF50 sunscreen
RxNorm normalized name: ZINC OXIDE 225 mg in 1 mL TOPICAL LOTION [People4Ocean SPF50 sunscreen]
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF50 sunscreen lotion
Trial: 18988091
Drug: SPF50 sunscreen
RxNorm normalized name: ZINC OXIDE 225 mg in 1 mL TOPICAL LOTION [People4Ocean SPF50 sunscreen]
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF50 sunscreen spray lotion
Trial: 16195164
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of the herbal remedy made from Rosa canina daily for 3 months
Trial: 9505981
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol 3350/electrolyte solution
Trial: 8445442
Drug: Ethamsylate (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethamsylate (12.5 mg/kg) given prophylactically within the first 4 hours of life followed by 6-hourly doses for 4 days
Trial: 31409166
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (400 mg cyclogest vaginal suppositories once daily)
Trial: 31409166
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone (250 mg of 17-hydroxyprogesterone caproate weekly)
Trial: 25392319
Drug: Subcutaneous Interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous Interferon beta (IFNb)
Trial: 25392319
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biomarkers (CASP2/IRF4/IRF6)
Trial: 25392319
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biomarkers (CASP2/IL10/IL12Rb1)
Trial: 20558036
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug with no side effects, no additional visit required, balanced information provided, results in the public domain, project approved by a research ethics committee.
Trial: 16544149
Drug: Endo-anal pudendal
RxNorm normalized name: Mephitis mephitis anal gland fluid preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endo-anal pudendal nerve stimulation daily at home with a portable home unit
Trial: 8558203
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (5 mg/kg bolus over 3 hours followed by 15 mg/kg infusion over 24 hours) plus paclitaxel (200 mg/m2 over 3 hours)
Trial: 6353927
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg relaxin
Trial: 6353927
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg relaxin
Trial: 30770754
Drug: L-AA
RxNorm normalized name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [WL-AAB-Z-W-330]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AA